The Society of Interventional Oncology (SIO) invites you to participate in its reimagined master class: the y90 NEXT Summit: Novel Explorations in Combination Therapies. This two-day course will be a unique opportunity to convene with multidisciplinary experts to discuss the role of y90 in combination therapy. The course will cover both glass and resin y90 data and delivery with lectures from expert faculty, in-depth discussions, and networking with industry partners.

A portion of the program will be held in partnership with the Society for Immunotherapy of Cancer (SITC) as a part of their Advances in Cancer Immunotherapy program. Registration will open in February 2025. 

Supported by Boston Scientific and Sirtex.